Unlike most studies of exhaled VOCs for diagnosis of HCC, to the best of our knowledge, this is the first study demonstrating that the exhaled VOC yielded better overall performance than AFP for diagnosis of HCC at any stage and HCC at an early stage. The gene discussed is AFP; the disease is hepatocellular carcinoma.